摘要
阿尔茨海默病(AD)是世界上最常见的痴呆症。尽管它的发现和病理表现集中于淀粉样蛋白- β (a β)和tau蛋白的过度磷酸化,但在过去的十年中,神经炎症已经成为该疾病的发病机制和进展的主要组成部分。小胶质细胞作为中枢神经系统(CNS)中主要的先天免疫细胞类型,在调节神经炎症中发挥着非常重要的作用,神经炎症常见于神经退行性疾病,包括AD。在炎症反应下,小胶质细胞发生形态变化,从稳态状态转变为激活状态。在AD中,不同的小胶质细胞亚型表现出不同的遗传特征,这些特征通常与从全基因组关联研究(GWAS)中识别出的AD风险基因有关,如APOE和TREM2。此外,许多AD风险基因在小胶质细胞中高度富集,并特异性影响小胶质细胞在发病过程中的功能,如释放炎症细胞因子和清除Aβ。因此,基于目前的临床前研究以及它们的致病或保护作用,建立小胶质细胞中这些风险基因的景观,将在很大程度上帮助我们理解AD复杂的病因,并为有效治疗的未满足的需求提供新的见解。
关键词: 阿尔茨海默病,小胶质细胞,神经炎症,AD风险基因,APOE, GWAS。
Current Alzheimer Research
Title:Microglia and its Genetics in Alzheimer's Disease
Volume: 18 Issue: 9
关键词: 阿尔茨海默病,小胶质细胞,神经炎症,AD风险基因,APOE, GWAS。
摘要: Alzheimer’s Disease (AD) is the most prevalent form of dementia across the world. While its discovery and pathological manifestations are centered on protein aggregations of amyloid- beta (Aβ) and hyperphosphorylated tau protein, neuroinflammation has emerged in the last decade as a main component of the disease in terms of both pathogenesis and progression. As the main innate immune cell type in the central nervous system (CNS), microglia play a very important role in regulating neuroinflammation, which occurs commonly in neurodegenerative conditions, including AD. Under inflammatory response, microglia undergo morphological changes and status transition from homeostatic to activated forms. Different microglia subtypes displaying distinct genetic profiles have been identified in AD, and these signatures often link to AD risk genes identified from the genome-wide association studies (GWAS), such as APOE and TREM2. Furthermore, many AD risk genes are highly enriched in microglia and specifically influence the functions of microglia in pathogenesis, e.g. releasing inflammatory cytokines and clearing Aβ. Therefore, building up a landscape of these risk genes in microglia, based on current preclinical studies and in the context of their pathogenic or protective effects, would largely help us to understand the complex etiology of AD and provide new insight into the unmet need for effective treatment.
Export Options
About this article
Cite this article as:
Microglia and its Genetics in Alzheimer's Disease, Current Alzheimer Research 2021; 18 (9) . https://dx.doi.org/10.2174/1567205018666211105140732
DOI https://dx.doi.org/10.2174/1567205018666211105140732 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
Current Stem Cell Research & Therapy Syntheses of Ethyl Pyruvate’s Bioisosteres Inhibiting Inducible Nitric Oxide Production in Lipopolysaccharide-induced BV2 Cells
Letters in Drug Design & Discovery Nitric Oxide Homeostasis in Neurodegenerative Diseases
Current Alzheimer Research Glaucoma Pathogenesis and Neurotrophins: Focus on the Molecular and Genetic Basis for Therapeutic Prospects
Current Neuropharmacology Amyotrophic Lateral Sclerosis: A Genetic Point of View
Current Molecular Medicine Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Neuroprotection and Regeneration Strategies for Spinal Cord Repair
Current Pharmaceutical Design Tetralogy of Fallot and Hypoplastic Left Heart Syndrome – Complex Clinical Phenotypes Meet Complex Genetic Networks
Current Genomics A Novel Approach for Substitution of Sulfonate Group by (1H)-imidazole moiety: An Application for Synthesis of Novel Benzyl Imidazolyl carbamates
Letters in Organic Chemistry Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis After Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neural Cell Adhesion Molecule
Current Gene Therapy Natural Animal Models of Neurodegenerative Protein Misfolding Diseases
Current Pharmaceutical Design Editorial (Thematic Issue: Current Update on Association Between Alzheimer’s Disease and Type 2 Diabetes: Volume I)
CNS & Neurological Disorders - Drug Targets GEMSP: A New Therapeutic Approach to Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy
Current Alzheimer Research Evaluation of Venom as a Promising Tool for Drug Discovery: Focusing on Neurological Disorders
Venoms and Toxins Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer’s Disease
Current Alzheimer Research The beneficial effect of Cape gooseberry juice on carbon tetrachloride-induced neuronal damage
CNS & Neurological Disorders - Drug Targets The Chaperone-like Activity of Rat HspB8/Hsp22 and Dynamic Molecular Transition Related to Oligomeric Architectures In Vitro
Protein & Peptide Letters Diffusion Tensor Imaging to Determine Effects of Antidementive Treatment on Cerebral Structural Connectivity in Alzheimer’s Disease
Current Pharmaceutical Design Recent Patents in Cell Therapy for Amyotrophic Lateral Sclerosis
Recent Patents on Regenerative Medicine